ArticleCirculation2018
Fate Mapping of Sca1
Abstract readLetter
In one paragraph
Article in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Nephron-associated Support Cell Transcriptional Plasticity Expands in Hypertension.bioRxiv : the preprint server for biology · 2026Article
- Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.International journal of molecular sciences · 2024Review
- Epicardium and Coronary Vessels.Advances in experimental medicine and biology · 2024Review
- Stem cell antigen-1Cellular and molecular life sciences : CMLS · 2023Article
- Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure.Journal of cardiovascular development and disease · 2022Review
- Article
- Mapping the cardiac vascular niche in heart failure.Nature communications · 2022Article
- The impact of autophagy modulation on phenotype and survival of cardiac stromal cells under metabolic stress.Cell death discovery · 2022Article
- Heart regeneration: 20 years of progress and renewed optimism.Developmental cell · 2022Review
- Cardiac regeneration: Options for repairing the injured heart.Frontiers in cardiovascular medicine · 2022Review
- Dynamic Epicardial Contribution to Cardiac Interstitial c-Kit and Sca1 Cellular Fractions.Frontiers in cell and developmental biology · 2022Article
- Resident stem cells in the heart.Medical review (2021) · 2021Article
- Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.Seminars in cell & developmental biology · 2021Review
- Sca1 marks a reserve endothelial progenitor population that preferentially expand after injury.Cell discovery · 2021Article
- Stem cell therapies in cardiac diseases: Current status and future possibilities.World journal of stem cells · 2021Review
- Article
- Cardiac Derived CD51-Positive Mesenchymal Stem Cells Enhance the Cardiac Repair Through SCF-Mediated Angiogenesis in Mice With Myocardial Infarction.Frontiers in cell and developmental biology · 2021Article
- Epicardial Contribution to the Developing and Injured Heart: Exploring the Cellular Composition of the Epicardium.Frontiers in cardiovascular medicine · 2021Review
- Single-cell gene profiling and lineage tracing analyses revealed novel mechanisms of endothelial repair by progenitors.Cellular and molecular life sciences : CMLS · 2020Article
- Stem cells and lung regeneration.American journal of physiology. Cell physiology · 2020Review
Corrections and comments
- Commented on by
Authors and funding
14 authors.
Juan TangState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Yan LiState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Xiuzhen HuangState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Lingjuan HeState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Libo ZhangState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Haixiao WangState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Wei YuState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Wenjuan PuState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Xueying TianKey Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China (X.T., B.Z.).
Yu NieState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (Y.N., S.H.).
Shengshou HuState Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (Y.N., S.H.).
Qing-Dong WangBioscience Heart Failure, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden (Q.-D.W.).
Kathy O LuiDepartment of Chemical Pathology; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong (K.O.L.).
Bin ZhouState Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences (J.T., Y.L., X.H., L.H., L.Z., H.W., W.Y., W.P., B.Z.).
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adult Stem CellsAnimalsAntigens, LyCell DifferentiationCell LineageCells, CulturedCell Self RenewalDisease Models, AnimalEndothelial CellsFibroblastsFlow CytometryHomeostasisHumansMembrane ProteinsMiceMice, TransgenicAntigens, LyLy6a protein, mouseMembrane ProteinsReceptor, Platelet-Derived Growth Factor alphaTamoxifencardiac progenitor cellcardiac regenerationcardiomyocytemyocardial infarctionSca1+
Identifiers
PMID
30566021What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.